G6PD deficiency: Difference between revisions
From IDWiki
(Imported from text file) |
No edit summary |
||
| Line 3: | Line 3: | ||
== Medications to Avoid == |
== Medications to Avoid == |
||
| − | * Dapsone (diaminodiphenyl sulfone) |
+ | * [[Dapsone]] (diaminodiphenyl sulfone) |
| − | * Methylene blue (methylthioninium chloride) |
+ | * [[Methylene blue]] (methylthioninium chloride) |
| − | * Nitrofurantoin, nifuratel and nitrofurazone (nitrofural) |
+ | * [[Nitrofurantoin]], [[nifuratel]] and [[nitrofurazone]] (nitrofural) |
| − | * Phenazopyridine (pyridium) |
+ | * [[Phenazopyridine]] (pyridium) |
| − | * Primaquine |
+ | * [[Primaquine]] |
| − | * Rasburicase and pegloticase |
+ | * [[Rasburicase]] and [[pegloticase]] |
Latest revision as of 12:00, 14 February 2022
- An X-linked recessive erythrocyte enzymopathy common in North Africa and the Mediterranean
Medications to Avoid
- Dapsone (diaminodiphenyl sulfone)
- Methylene blue (methylthioninium chloride)
- Nitrofurantoin, nifuratel and nitrofurazone (nitrofural)
- Phenazopyridine (pyridium)
- Primaquine
- Rasburicase and pegloticase
